Second, we used IL-23OE in the arthritis-resistant C57BL/6 inbred strain and intervened every second day with anti-CD200 treatment (OX-90) to block the suppression of skin-derived precursors by resident CD200+ fibroblasts. This evidence concerns the gene CD200 and arthritic joint disease.